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A role for thyroid hormones in the regulation of the rhythmic expression of 
circadian clock genes is suggested by the finding that surgical removal of the 
thyroid gland alters circadian behavioral and endocrine rhythms in rodents.  
Virtually nothing is known about the role of thyroid hormones in the regulation of 
clock genes responsible for the generation of circadian rhythmicity.  To study this 
issue, we assessed in rats the effect of thyroidectomy/parathyrodectomy (TPX) 
on the expression of the clock protein, PER2, in the suprachiasmatic nucleus 
(SCN), the master circadian clock, and in a number of key limbic forebrain 
structures, the oval nucleus of the bed nucleus of the stria terminalis (BNST-OV), 
the central nucleus of the amygdala (CEA), the basolateral amygdala (BLA) and 
the dentate gyrus (DG).  TPX significantly altered the normal daily pattern of 
PER2 expression in the BNSTov and CEA, but had no effect on PER2 
expression in the SCN, BLA and DG.  Thus, although thyroid hormones modulate 
PER2 expression in the brain, the effect is tissue specific and therefore likely not 
to be mediated by a direct effect of the hormone on gene expression. 
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Thyroid hormones appear to play a role in the regulation of behavioral and 
physiological circadian rhythms in mammals.  This involvement is suggested by 
the evidence that surgical removal of the thyroid and parathyroid glands or 
chemical induction of hypothyroidism alters circadian locomotor activity rhythms 
and blunts the daily fluctuations in circulating corticosterone and prolactin levels 
in rodents [3, 18-21, 24].  How thyroid hormones might affect circadian rhythms is 
unknown.  One possibility is that these hormones modulate the expression of 
clock genes implicated in the generation of circadian rhythms at the cellular level.  
To begin to study the involvement of thyroid hormones in the regulation of the 
expression of circadian clock genes, we examined the effect of 
thyroparathyrodectomy (TPX) on the rhythm of expression of the clock protein, 
PER2, in the suprachiasmatic nucleus (SCN), the master circadian clock, in rats.  
Furthermore, we assessed the effect of TPX on the expression of PER2 in 
several limbic forebrain structures shown to exhibit robust PER2 rhythms that are 
under the control of the SCN, the oval nucleus of the bed nucleus of the stria 
terminalis (BNSTov), central nucleus of the amygdala (CEA), basolateral 
amygdala (BLA) and dentate gyrus (DG) [2, 17].  
 
The experimental procedures followed the guidelines of the Canadian Council on 
Animal Care and were approved by the Animal Care Committee, Concordia 
University.  A total of 12 thyrodectomized/parathyrodectomized (TPX) and 12 
sham-operated (SHAM) male Sprague Dawley rats (Hsd:SD, 4 weeks old, 50-
75g) were purchased from Harlan (Indianapolis, Indiana).  They were housed two 
per cage in a temperature- and humidity-controlled room under a normal 12h:12h 
light-dark (LD) cycle (300 lux at cage level) and had free access to food and 
water.  Three weeks later they were transferred to individual cages housed in 
ventilated, sound and light tight isolation chambers and kept under a 12h:12h LD 
cycle with free access to food and water.  One month later, the rats were injected 
with an overdose of sodium pentobarbital (~100 mg/kg) at one of two zeitgeber 
times (ZT1, ZT13; ZT0 denotes time of light on) and were perfused intracardially 
with 300 ml of cold saline (0.9% NaCl) followed by 300 ml of cold, 4% 
paraformaldehyde in a 0.1 M phosphate buffer (pH 7.3).  ZT1 and ZT13 were 
chosen because they represent peak and trough expression times of PER2 
protein in all brain regions studied.  Following perfusion, brains were postfixed in 
4% paraformaldehyde and stored at 4° C overnight.  Serial coronal brain sections 
(50 µm) containing regions of interest (SCN, BNST, amygdala, hippocampus) 
were collected from each animal using a vibratome.  Immunocytochemistry for 
PER2 was performed as previously described [17] using an affinity purified rabbit 
polyclonal antibody raised against PER2 (ADI, San Antonio, TX).  
Immunostaining was performed in two separate runs each containing brain 
sections from rats from the two time points (ZT1, ZT13) and treatment groups 
(TPX, Sham).  Evidence for antibody specificity was obtained in blocking 
experiments performed previously in our laboratory by adding the PER2 peptide 
(1 mg/ml, diluted 1:100) to the primary incubation solution.  The addition of the 
PER2 peptide prevented PER2 immunostaining staining in all regions of interest 
[2].  
 PER2-stained brain sections were examined under a light microscope 
and images were captured using a Sony XC-77 video camera, a Scion LG-3 
frame grabber, and Image SXM software (v1.6, S D Barrett, 
http://www.ImageSXM.org.uk).  All cells exhibiting strong nuclear PER2 
immunostaining were counted manually on the captured images using a 400 x 
400-µm template for the SCN, BNSTov, CEA, BLA and 200 x 400-µm template 
for the DG.  For analysis, the mean number of PER2 immunoreactive cells per 
region was calculated for each animal from the counts of 6 unilateral images 
showing the highest number of labeled nuclei.  Differences between groups were 
revealed with analysis of variance (ANOVA).  Alpha level was set at 0.05 for all 
analyses. 
 
Examples of PER2 expression in the SCN, BNSTov, CEA, BLA and DG of 
SHAM rats killed at ZT1 or ZT13, and graphs showing the effect of TPX on the 
levels of PER2 in each of these regions are shown in Fig. 1.  In the SCN PER2 
expression was high at ZT13 (F[1,20]=1552.6, p<.0001]) and TPX had no effect 
on the overall level of expression (F[1,20]=1.76, p=.198).  Similarly, as shown in 
Fig. 1, in both the BNSTov and CEA PER2 expression was high at ZT13 
(BNSTov: F[1,20]=57.6, p<.0001; CEA: F[1,20]=36.63, p<.0001) and no 
significant main effect of treatment on the level of expression was noted 
(BNSTov: F[1,20]=.47, p=.50; CEA: F[1,20]=1.7, p=.19).  However, a significant 
Treatment x Time interaction was observed in both the BNSTov ( F[1,20]=11.07, 
p<.005) and CEA (F[1,20]=11.39, p<.005).  Post-hoc analysis revealed a 
significant increase in PER2 expression in the BNSTov and CEA of TPX rats at 
ZT1 (Tukey, p<.05).  In the BLA and DG PER2 expression peaked at ZT1 (BLA: 
F[1,20]=78.7, p<.0001; DG: F[1,20]=227.5, p<.0001).  Furthermore, TPX had no 
effect on PER2 expression in BLA ( F[1,20]=.4, p=.534) and DG (F[1,20]=.093, 
p=.764) and no significant Time x Treatment interaction was noted.   
 
The results show that surgical removal of the thyroid and parathyroid 
glands alters the normal daily pattern of expression of the clock protein, PER2 in 
the BNSTov and CEA in rats.  Specifically, TPX led to a significant increase in 
PER2 expression at ZT1, when PER2 expression in the BNSTov and CEA is 
normally low, and to a small decrease in expression at ZT13, when PER2 
expression is normally high in these areas .  These changes in PER2 expression 
may reflect a blunting effect of TPX on the rhythm of PER2 expression in these 
areas [2, 17].  Alternatively, it is possible that TPX changed the phase of peak 
expression of PER2 and/or the waveform of expression (e.g., duration of peak 
expression) without affecting the amplitude of expression.  The research design 
employed in this study in which the expression of PER2 was assessed only at 
two time points representing the normal peak and trough of PER2 expression 
(i.e., ZT1 and ZT13) does not allow for a definitive distinction between these 
alternatives.  Contrary to the change in PER2 expression in the BNSTov and 
CEA, the expression of PER2 in the SCN, BLA and DG was not affected, 
demonstrating that the effect of removal of the thyroid and parathyroid glands on 
PER2 expression is region specific. 
 The mechanism whereby thyroid hormones might selectively affect PER2 
in the BNSTov and CEA remains to be determined.  Thyroid hormones such as 
thyroxine (T4) and triiodothyronine (T3) might affect PER2 expression by directly 
or indirectly modulating the transcription of the Per2 gene.  Such a mechanism, 
however, is unlikely to explain the lack of effect of TPX on PER2 expression in 
the SCN, BLA and DG.  Rather, the selective effect of TPX on PER2 expression 
in the BNSTov and CEA may be related to findings that TPX blunts the daily 
rhythm of plasma corticosterone levels [11, 20, 21, 26].  Indeed, we have shown 
previously that the rhythm of expression of PER2 in the BNSTov and CEA, but 
not in the SCN, BLA and DG is controlled by the glucocorticoid hormone, 
corticosterone.  Specifically, we found that surgical removal of the adrenal glands 
selectively abolished the daily rhythm of PER2 expression in the BNSTov and 
CEA [2, 17] and that treatment that restored the daily rhythm of circulating 
corticosterone restored PER2 rhythms in these brain regions [25].  Finally, an 
effect of TPX on neurotransmitters and peptides such as dopamine and 
corticotropin-releasing hormone, that might be involved in the regulation of PER2 
expression in the BNSTov and CEA could be envisioned [22, 23, 27, 29]. 
The release of thyroid hormones into the circulation exhibits a circadian 
rhythm [13, 14], and previous studies have shown that surgical removal of the 
thyroid and parathyroid glands shortens the free running period of locomotor 
activity rhythms in rats [18, 19].  Such results support the hypothesis that  
fluctuating levels of thyroid hormones modulate circadian rhythmicity by 
modulating the expression of clock genes in the SCN.  The present finding that 
TPX had no effect on the rhythm of expression of PER2 in the SCN suggests that 
the effect of circulating thyroid hormones on circadian period is independent of 
an effect on the expression of clock genes in the SCN and is more likely 
mediated downstream from the SCN oscillator. 
 
Finally, the present results show that TPX affects PER2 expression in two 
limbic forebrain structures, the BNST-OV and CEA, known to play key roles in 
regulation of emotional states and the control of physiological and endocrine 
responses to stress [1, 4, 5, 8, 10].  These results may be relevant, therefore, to 
the observation that, in humans, abnormalities of thyroid function are often 
associated with emotional disturbances and depressive illness [6, 7, 9, 12], and 
with the observation that such affective disorders are commonly associated with 
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Fig. 1 
a: Photomicrographs showing examples of PER2 expression in the SCN, 
BNSTov, CEA, BLA and DG of sham-operated (SHAM) and 
thyroidectomized/parathyroidectomized (TPX) rats killed at ZT1 or ZT13 
(magnification=x20). b: Graphs showing the mean (±s.e.m.) number of PER2-
immunoreactive nuclei as a function of zeitgeber time (ZT) in each of these 
regions in SHAM (n=6/time point) and TPX (n=6/time point) rats.  Asterisks 
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Reviewer #1  
 
We agree with the reviewer that the argument concerning the involvement of 
REV-ERB and ROR as possible targets of thyroid hormones’ effect on clock 
gene expression is not sufficiently supported in the literature, and we thank him 
for pointing out the source of the confusion.  In our revised manuscript we have 






We addressed all the comments of this reviewer by adding the appropriate 
information.  Specifically, in response to comment about antibody specificity we 
include a statement on our published ‘blocking experiments’ using the PER2 
peptide; furthermore, we indicate in the methods sections that each of the two 
immunocytochemical assays we performed contained  brain sections from rats 
from the two time points and conditions (Sham, TPX); we elaborate more on the 
counting procedure (all cells strongly immunoreactive to PER2 within region of 
interest are counted using a fixed size templates); finally, as recommended by 
the reviewer, in Fig. 1 we add a set of images from each of the regions under 
study taken from TPX rats killed at ZT1 or ZT13. 
 
* Response to Reviews
